9572
S.J. Balkrishna et al. / Tetrahedron 67 (2011) 9565e9575
127.67, 126.35, 126.28, 121.0, 113.1, 56.2. IR (plate): 2920, 1670, 1634,
1496, 1442, 1342, 1269, 1246, 1107, 1045, 1022, 741 cmꢃ1. ESMS (ESI)
m/z: 306 (MþHþ). HRMS (ESI) m/z 306.0040 (calcd for
C14H11N1O820Se1þHþ: 306.0033).
7.36e7.32 (m, 5H), 7.19 (dd, J¼8.5, 3.0 Hz, 1H), 5.00 (s, 2H), 3.88 (s,
3H). 13C NMR (125 MHz, CDCl3)
166.9, 158.7, 137.1, 129.1, 128.6,
128.29, 128.26, 128.01, 124.9, 121.6, 110.5, 55.5, 48.6. IR (plate):
d
2925, 1603, 1470, 1342, 1274, 1230, 1126, 1150, 1022, 700 cmꢃ1
.
HRMS (ESI) m/z 320.0194 (C15H13N1O2 80Se1þHþ: 320.0184).
5.1.9. 2-Chloro-3-methoxy-N-phenylbenzamide (substrate for Iso-
selenazolone 8). 2-Chloro-3-methoxybenzoyl chloride (0.95 g,
5.0 mmol) was dissolved in dry CH2Cl2 (15 mL) in a single neck flask
and cooled to 0 ꢀC. Aniline (0.95 g,10.1 mmol) in 10 mL of CH2Cl2 was
slowly added to this solution by dropping funnel. Resulted reaction
mixture was stirred for 1 h at 0 ꢀC and 12 h at room temperature.
After this, water (50 mL) was added to the reaction flask and stirred
for 30 min. Organic layer was extracted with CH2Cl2 (50 mLꢂ3) and
water layer separated by separating funnel. Organic layer was
washed with 10% aqueous HCl (25 mL), with water (25 mL), dried
over Na2SO4, and evaporated on rotary evaporator under vacuo. The
resulted white solid was passed through silica gel using CH2Cl2 to
obtain pure amide. Rf (3% DCM/MeOH) 0.6. Yield 1.26 g (95%), mp
5.1.13. 6,7-Dimethoxy-2-phenylbenzo[d][1,2]selenazol-3(2H)-one
(11). 6,7-Dimethoxy isoselenazolone 11 was prepared from 2-
chloro-3,4-dimethoxy-N-phenylbenzamide23 (0.5 g, 1.7 mmol),
copper iodide (164 mg, 0.9 mmol), 1,10-phenanthroline (154 mg,
0.9 mmol), selenium powder (0.16 g, 2.0 mmol), and potassium
carbonate (0.94 g, 6.8 mmol). The reaction mixture was refluxed for
24 h. Workup and purification procedures are similar as described
for compound 2. Yield 252 mg, 44%, mp 139e141 ꢀC (139e141 ꢀC).15
1H NMR (500 MHz, CDCl3)
2H), 7.42 (t, J¼8.5 Hz, 2H), 7.26 (m, 1H), 7.09 (d, J¼8.5 Hz, 1H), 4.003
(s, 3H), 3.997 (s, 3H). 13C NMR (125 MHz, CDCl3)
165.8,154.7,142.2,
139.5, 131.3, 129.3, 126.5, 125.3, 125.2, 121.3, 112.7, 60.5, 56.3. IR
d
7.82 (d, J¼8.5 Hz, 1H), 7.61 (d, J¼8.5 Hz,
d
140e142 ꢀC. 1H NMR (500 MHz, CDCl3)
d
7.83 (br s, 1H), 7.63 (d,
(plate): 2925, 2853, 1664, 1599, 1492, 1441, 1281, 1040, 744 cmꢃ1
.
J¼8.0 Hz, 2H), 7.37 (t, J¼7.5 Hz, 2H), 7.31 (t, J¼8.0 Hz, 1H), 7.27e7.25
HRMS (ESI) m/z 336.0134 (C15H13N1O3 80Se1þHþ: 336.0133).
(m,1H), 7.16 (t, 7.5 Hz,1H), 7.02 (dd, J¼8.0,1.2 Hz,1H), 3.93 (s, 3H).13C
NMR (125 MHz, CDCl3)
d
164.7, 155.3, 137.6, 137.1, 129.0, 127.8, 124.7,
5.1.14. 2-Benzyl-5-(methylthio)benzo[d][1,2]selenazol-3(2H)-one
(12). Heterocycle 7 was prepared from copper iodide (82 mg,
0.4 mmol), 1,10-phenanthroline (77 mg, 0.4 mmol), 2-chloro-5-
(methylthio)-N-benzylbenzamide28 (0.50 g, 1.7 mmol), selenium
powder (0.16 g, 2.1 mmol), and potassium carbonate (0.94 g,
6.8 mmol) in DMF (8 mL). Resulted reaction mixture was heated for
36 h at 110 ꢀC. Reaction workup procedure is similar to 2. Purifi-
cation was carried out by using hexane/ethyl acetate (8:2) on silica
gel. Rf (20% Hexane/EtOAc) 0.6. Yield (223 mg, 39%), mp
121.2,120.1,119.4,113.6, 56.4. IR (plate): 3282, 3071, 3011, 2929,1655,
1599, 1495, 1440, 1326, 1273, 1054, 754 cmꢃ1
.
5.1.10. 7-Methoxy-2-phenylbenzo[d][1,2]selenazol-3(2H)-one
(8). Isoselenazolone was synthesized using CuI (76 mg,
8
0.4 mmol), 1,10-phenanthroline (72 mg, 0.4 mmol), 2-chloro-3-
methoxy-N-phenylbenzamide (0.21 g, 0.8 mmol), selenium pow-
der (0.07 g, 0.9 mmol), and K2CO3 (0.42 g, 3.0 mmol) in DMF (3 mL).
Reaction mixture was heated at 110 ꢀC for 24 h. Workup and pu-
rification for this compound is similar to the isoselenazolone 2. Rf
(100% DCM) 0.4. Yield 137 mg, 57%, mp 138e141 ꢀC (139e140 ꢀC).15
139e141 ꢀC. 1H NMR (500 MHz, CDCl3)
J¼8.5 Hz, 1H), 7.44 (d, J¼8.5 Hz, 1H), 7.38e7.34 (m, 5H), 5.00 (s, 2H),
2.56 (s, 3H). 13C NMR (100 MHz, CDCl3)
166.7, 137.7, 137.1, 134.4,
d 7.91 (s, 1H), 7.47 (d,
d
1H NMR (500 MHz, CDCl3)
2H), 7.44 (q, J¼7.5 Hz, 3H), 7.28 (t, J¼7.5 Hz, 1H), 7.07 (d, J¼8.0 Hz,
1H), 3.97 (s, 3H). 13C NMR (125 MHz, CDCl3)
165.9, 154.1, 139.4,
d
7.71 (d, J¼3.0 Hz, 1H), 7.63 (d, J¼8.5 Hz,
130.9, 128.9, 128.5, 128.3, 128.1, 125.4, 124.2, 48.7, 15.9. IR (plate):
2918, 1590, 1543, 1449, 1337, 1079, 816, 761, 695 cmꢃ1. HRMS (ESI)
m/z 335.9968 (C15H13N1O1S1 80Se1þHþ: 335.9956).
d
129.3, 128.87, 128.26, 126.84, 126.62, 125.3, 121.1, 112.2, 56.0. IR
(plate): 2922, 1640, 1590, 1454, 1299, 1270, 1135, 733 cmꢃ1. HRMS
(ESI) m/z 306.0055 (C14H11N1O2 80Se1þHþ: 306.0027).
5.1.15. 2-Benzyl[1,2]selenazolo[5,4-b]pyridin-3(2H)-one
(13). Isoselenazolone 13 containing pyridine moiety was con-
structed from N-benzyl-2-chloronicotinamide29 (0.4 g, 1.6 mmol),
CuI (310 mg, 1.6 mmol), 1,10-phenanthroline (292 mg, 1.6 mmol),
selenium powder (0.19 g, 2.4 mmol), and K2CO3 (0.45 g, 3.2 mmol)
in DMF (5 mL). Resulted reaction mixture was refluxed for 22 h at
110 ꢀC. Workup was carried out by pouring reaction mixture into
saturated NaHCO3 aqueous solution followed by extraction with
EtOAc (25 mLꢂ5). Crude product obtained after evaporating EtOAc
layer and purified by column chromatography on silica gel using
CH2Cl2 and EtOAc (8:2). Rf (20% DCM/EtOAc) 0.5 afforded a white
crystalline solid. X-ray quality crystals were obtained by using
CH2Cl2 and hexane (9:1) solvent mixture. 0.234 g (50%), mp:
5.1.11. 2-Benzyl-7-methoxybenzo[d][1,2]selenazol-3(2H)-one
(9). Isoselenazolone 9 was prepared by following similar method
as described for 3 from 2-chloro-3-methoxy-N-benzylbenzamide23
(0.30 g, 1.1 mmol), CuI (104 mg, 0.5 mmol), 1,10-phenanthroline
(98 mg, 0.5 mmol), selenium powder (0.10 g, 1.3 mmol), and
K2CO3 (0.61 g, 4.4 mmol) in DMF (5 mL). The resulted reaction
mixture was stirred for 24 h at 110 ꢀC. Workup procedure is similar
to 2. Compound 9 was purified by column chromatography using
silica gel and eluent hexane/ethyl acetate (8:2). Rf (20% Hexane/
EtOAc) 0.2. Yield 232 mg, 67%, mp 66e68 ꢀC. 1H NMR (500 MHz,
CDCl3)
d
7.69 (d, J¼8.0 Hz, 1H), 7.41 (t, J¼8.0 Hz, 1H), 7.62e7.32 (m,
162e164 ꢀC. 1H NMR (500 MHz, CDCl3)
d
8.68 (d, J¼5.0 Hz, 1H), 8.28
5H), 6.99 (t, J¼8.0 Hz, 1H), 5.00 (s, 2H), 3.91 (s, 3H). 13C NMR
(d, J¼8.0 Hz, 1H), 7.39 (d, J¼5.0 Hz, 1H), 7.38e7.36(m, 5H), 5.03(s,
2H). 13C NMR (100 MHz, CDCl3): 165.3, 162.1, 152.9, 151.1, 136.9,
136.6, 128.9, 128.6, 128.5, 121.5, 48.5 IR (plate): 2921, 2853, 1648,
1579, 1388, 1324, 1228, 1081, 749, 698 cmꢃ1. HRMS (ESI) m/z
291.0037 (C13H10N2O180Se1þHþ: 291.0031).
(125 MHz, CDCl3) d 167.4, 154.3, 137.3, 128.78, 128.51, 128.23, 127.92,
127.80, 127.33, 120.6, 111.7, 55.9, 48.7. IR (plate): 3030, 2926, 1644,
1578, 1479, 1270, 1071, 740 cmꢃ1. HRMS (ESI) m/z 320.0196
(C15H13N1O2 80Se1þHþ: 320.0184).
5.1.12. 2-Benzyl-5-methoxybenzo[d][1,2]selenazol-3(2H)-one
(10). 5-Methoxybenzyl isoselenazolone 10 was prepared from 2-
bromo-5-methoxy-N-benzylbenzamide27 (0.50 g, 1.6 mmol), cop-
per iodide (74 mg, 0.4 mmol), 1,10-phenanthroline (71 mg,
0.4 mmol), selenium powder (0.15 g, 1.9 mmol), and potassium
carbonate (0.32 g, 2.3 mmol). The reaction mixture was refluxed for
22 h. Workup and purification procedures are similar as described
for compound 2. Yield 380 mg, 76%, mp 124e126 ꢀC. 1H NMR
5.1.16. 2-Cyclohexyl[1,2]selenazolo[5,4-b]pyridin-3(2H)-one
(14). For the preparation of cyclohexyl containing SeeN hetero-
cycle 14, reaction was carried in a similar manner as described for
13 by using N-cyclohexyl-2-chloronicotinamide30 (0.7 g, 2.9 mmol),
CuI (560 mg, 2.9 mmol), 1,10-phenanthroline (530 mg, 2.9 mmol),
selenium powder (0.34 g, 4.3 mmol), and K2CO3 (3.0 g, 21.7 mmol)
in DMF (7 mL) and resulted reaction mixture was refluxed for 48 h
at 110 ꢀC. Standard workup as described for 13, and purification by
column chromatography on silica gel using CH2Cl2 and EtOAc (8:2)
(500 MHz, CDCl3)
d
7.57 (d, J¼3.0 Hz, 1H), 7.43 (d, J¼8.5 Hz, 1H),